At present, the Molecular Diagnostics business is powered by the Aptima BV, CV/TV assay, Hologic’s second-largest assay globally, which posted a strong double-digit rate in the first quarter of ...

It provides Aptima molecular ... and Rapid Fetal Fibronectin Test that assists physicians in assessing the risk of pre-term birth. Receive News & Ratings for Hologic Daily - Enter your email ...

It provides Aptima molecular ... and Rapid Fetal Fibronectin Test that assists physicians in assessing the risk of pre-term birth. Receive News & Ratings for Hologic Daily - Enter your email ...

Additionally, the respiratory 4-plex, COVID/Flu A/B/RSV assay may have contributed to Diagnsotics’ growth in the second quarter. In February 2025, Hologic’s Aptima SARS-CoV-2 assay was granted ...

Hologic, Inc.’s HOLX fiscal 2025 second-quarter financial results, set to release on May 1 after the market closes, will ...

are Roche’s Cobas CT/NG test (44.3 per cent) and Hologic’s Aptima Combo 2 assay (42.4 per cent). Based on GlobalData’s MedSource Database, a database on the medical device supply chain, the Aptima ...